TAAR1 agonist reduces α-NETA induced dyskinesia
DOI:
https://doi.org/10.33910/2687-1270-2023-4-3-346-355Keywords:
trace amines, trace amine-associated receptors, TAAR1, TAAR5, α-NETA, dyskinesia, knockout mice, TAAR1 agonist RO5263397Abstract
As of today, sufficient evidence has been collected regarding the role of trace amines (TAs) as neuromodulators in the mammalian central nervous system. TAs share structural similarities with classical biogenic amines, while the changes in their concentration have been linked to various mental disorders. Two widely expressed members of the TAs receptor family in the human central nervous system are TAAR1 and TAAR5 receptors. The first part of this research investigates the behavioral effects of α-NETA injection (2-(alpha-naphthoyl) ethyltrimethylammonium iodide, 10 mg/kg, IP) on both TAAR5 knockout (KO TAAR5) and wild-type (WT) mice. The second part examines the impact of the TAAR1 agonist, RO 5263397, on dyskinesia induced by α-NETA injection in C57BL/6 male mice. The α-NETA (10 mg/kg) injection causes dyskinesia both in wild-type and KO TAAR5 mice, suggesting that α-NETA-induced dyskinesia is unrelated to the effects on TAAR5 receptors. The second part of the study found that preliminary administration of a high dose (1 mg/kg) of a TAAR1 agonist inhibited α-NETA-induced dyskinesia 90 min after injection. In addition, the number of expanded dyskinesias was significantly reduced in groups pre-injected with TAAR1 agonist. These findings suggest that TAAR1 agonists hold promise for the treatment of certain forms of dyskinesia.
References
Aleksandrov, A. A., Dmitrieva, E. S., Volnova, A. B. et al. (2019a) Effect of alpha-NETA on auditory event related potentials in sensory gating study paradigm in mice. Neuroscience Letters, vol. 712, no. 2, article 134470. https://doi.org/10.1016/j.neulet.2019.134470 (In English)
Aleksandrov, A. A., Dmitrieva, E. S., Volnova, A. B. et al. (2019b) Effect of trace amine-associated receptor 1 agonist RO5263397 on sensory gating in mice. NeuroReport, vol. 30, no. 15, pp. 1004–1007. https://doi.org/10.1097/WNR.0000000000001313 (In English)
Aleksandrov, A. A., Knyazeva, V. M., Volnova, A. B. et al. (2019c) Trace amine-associated receptor 1 agonist modulates mismatch negativity-like responses in mice. Frontiers in Pharmacology, vol. 10, article 470. https://doi.org/10.3389/fphar.2019.00470 (In English)
Aleksandrov, A. A., Polyakova, N. V., Vinogradova, E. P. et al. (2019d) The TAAR5 agonist α-NETA causes dyskinesia in mice. Neuroscience Letters, vol. 704, pp. 208–211. https://doi.org/10.1016/j.neulet.2019.04.028 (In English)
Alvarsson, A., Zhang, X., Stan, T. L. et al. (2015) Modulation by trace amine-associated receptor 1 of experimental parkinsonism, L-DOPA responsivity, and glutamatergic neurotransmission. Journal of Neuroscience, vol. 35, no. 41, pp. 14057–14069. https://doi.org/10.1523/JNEUROSCI.1312-15.2015 (In English)
Berry, M. D., Gainetdinov, R. R., Hoener, M. C., Shahid, M. (2017) Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges. Pharmacology & Therapeutics, vol. 180, pp. 161–180. https://doi.org/10.1016/j.pharmthera.2017.07.002 (In English)
Boulton, A. A. (1980) The properties and potential function of some brain trace amines. Progress in Clinical and Biological Research, vol. 39, pp. 291–303. https://pubmed.ncbi.nlm.nih.gov/6105673 (In English)
Branchek, T. A., Blackburn, T. P. (2003) Trace amine receptors as targets for novel therapeutics: Legend, myth and fact. Current Opinion in Pharmacology, vol. 3, no. 1, pp. 90–97. https://doi.org/10.1016/s1471-4892(02)00028-0 (In English)
Chagraoui, A., Boulain, M., Juvin, L. et al. (2020) L-DOPA in Parkinson’s disease: Looking at the “false” neurotransmitters and their meaning. International Journal of Molecular Sciences, vol. 21, no. 1, article 294. https://doi.org/10.3390/ijms21010294 (In English)
Charan, J., Kantharia, N. D. (2013) How to calculate sample size in animal studies? Journal of Pharmacology and Pharmacotherapeutics, vol. 4, no. 4, pp. 303–306. https://doi.org/10.4103/0976-500X.119726 (In English)
DasGupta, A. (2008) Asymptotic theory of statistics and probability. New York: Springer Publ., 722 p. https://doi.org/10.1007/978-0-387-75971-5 (In English)
Dinter, J., Mühlhaus, J., Wienchol, C. L. et al. (2015) Inverse agonistic action of 3-iodothyronamine at the human trace amine-associated receptor 5. PLoS One, vol. 10, no. 2, article e0117774. https://doi.org/10.1371/journal.pone.0117774 (In English)
Espinoza, S., Manago, F., Leo, D. et al. (2012) Role of catechol-O-methyltransferase (COMT)-dependent processes in Parkinson’s disease and L-DOPA treatment. CNS & Neurological Disorders-Drug Targets, vol. 11, no. 3, pp. 251–263. https://doi.org/10.2174/187152712800672436 (In English)
Espinoza, S., Salahpour, A., Masri, B. et al. (2011) Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor. Molecular Pharmacology, vol. 80, no. 3, pp. 416–425. https://doi.org/10.1124/mol.111.073304 (In English)
European Convention for the protection of vertebrate animals used for experimental and other scientific purposes. (1986) Strasbourg: [s. n.], 11 p. (In English)
Fried, R., Dehling, H. (2011) Robust nonparametric tests for the two-sample location problem. Statistical Methods & Applications, vol. 20, no. 4, pp. 409–422. https://doi.org/10.1007/s10260-011-0164-1 (In English)
Gainetdinov, R. R., Hoener, M. C., Berry, M. D. (2018) Trace amines and their receptors. Pharmacological Reviews, vol. 70, no. 3, pp. 549–620. https://doi.org/10.1124/pr.117.015305 (In English)
Kumar, R., Kumar, A., Långström, B., Darreh-Shori, T. (2017) Discovery of novel choline acetyltransferase inhibitors using structure-based virtual screening. Scientific Reports, vol. 7, no. 1, article 16287. https://doi.org/10.1038/s41598-017-16033-w (In English)
Lindemann, L., Meyer, C. A., Jeanneau, K. et al. (2008) Trace amine-associated receptor 1 modulates dopaminergic activity. Journal of Pharmacology and Experimental Therapeutics, vol. 324, no. 3, pp. 948–956. https://doi.org/10.1124/jpet.107.132647 (In English)
Panas, H. N., Lynch, L. J., Vallender, E. J. et al. (2010) Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice. Journal of Neuroscience Research, vol. 88, no. 9, pp. 1962–1969. https://doi.org/10.1002/jnr.22367 (In English)
Pei, Y., Asif-Malik, A., Canales, J. J. (2016) Trace amines and the trace amine-associated receptor 1: Pharmacology, neurochemistry, and clinical implications. Frontiers in Neuroscience, vol. 10, article 148. https://doi.org/10.3389/fnins.2016.00148 (In English)
Revel, F. G., Moreau, J.-L., Gainetdinov, R. R. et al. (2011) TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proceedings of the National Academy of Sciences, vol. 108, no. 20, pp. 8485–8490. https://doi.org/10.1073/pnas.1103029108 (In English)
Revel, F. G., Moreau, J. L., Pouzet, B. et al. (2013) A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic-and antidepressant-like activity, improve cognition and control body weight. Molecular Psychiatry, vol. 18, no. 5, pp. 543–556. https://doi.org/10.1038/mp.2012.57 (In English)
Shitikov, V. K., Rosenberg, G. S. (2013) Randomizatsiya i butstrep: statisticheskij analiz v biologii i ekologii s ispol’zovaniem R [Randomization and bootstrap: Statistical analysis in biology and ecology using R]. Tolyatti: Kassandra Publ., 314 p. (In Russian)
Simmler, L. D., Buchy, D., Chaboz, S. et al. (2016) In vitro characterization of psychoactive substances at rat, mouse, and human trace amine-associated receptor 1. Journal of Pharmacology and Experimental Therapeutics, vol. 357, no. 1, pp. 134–144. https://doi.org/10.1124/jpet.115.229765 (In English)
Sotnikova, T. D., Zorina, O. I., Ghisi, V. et al. (2008) Trace amine associated receptor 1 and movement control. Parkinsonism & Related Disorders, vol. 14, no. 2. Supplement, pp. S99–S102. https://doi.org/10.1016/j.parkreldis.2008.04.006 (In English)
Vinogradova, E. P., Polyakova, N. V., Stankevich, L. N., Aleksandrov, A. A. (2020) Vliyanie agonista TAAR5 α-NETA na povedenie myshej linii C57Bl/6 [Effects of TAAR5 α-NETA agonist on behavior in C57Bl/6 mice]. Zhurnal vysshej nervnoj deyatel’nosti imeni I. P. Pavlova — I. P. Pavlov Journal of Higher Nervous Activity, vol. 70, no. 1, pp. 62–70. https://doi.org/10.31857/S0044467719060133 (In Russian)
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Nadezhda V. Polyakova, Anton Yu. Aleksandrov, Veronika M. Knyazeva, Ekaterina P. Vinogradova, Elena S. Dmitrieva, Ludmila N. Stankevich, Aleksandr A. Aleksandrov
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The work is provided under the terms of the Public Offer and of Creative Commons public license Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). This license allows an unlimited number of persons to reproduce and share the Licensed Material in all media and formats. Any use of the Licensed Material shall contain an identification of its Creator(s) and must be for non-commercial purposes only.
